Role of the p53-homologue p73 in E2F1-induced apoptosis (Q38306110)

2 September 2017

title

Role of the p53-homologue p73 in E2F1-induced apoptosis (English)

1 reference

2 September 2017

1 reference

T Stiewe

1

0 references

author name string

B M Pützer

series ordinal

2

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

2 September 2017

1 reference

2 September 2017

volume

26

1 reference

2 September 2017

issue

4

1 reference

2 September 2017

page(s)

464-469

1 reference

Tumor surveillance via the ARF-p53 pathway.

2 September 2017

cites work

1 reference

Induction of DNA synthesis and apoptosis are separable functions of E2F-1.

21 January 2018

1 reference

p14ARF links the tumour suppressors RB and p53.

21 January 2018

1 reference

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

21 January 2018

1 reference

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

21 January 2018

1 reference

p73 is a simian [correction of human] p53-related protein that can induce apoptosis

21 January 2018

1 reference

CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase

21 January 2018

1 reference

The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis

21 January 2018

1 reference

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

21 January 2018

1 reference

E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways

21 January 2018

1 reference

Analysis of p73 in human borderline and invasive ovarian tumor

21 January 2018

1 reference

Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein

21 January 2018

1 reference

A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4.

21 January 2018

1 reference

Exogenous E2F expression is growth inhibitory before, during, and after cellular transformation

21 January 2018

1 reference

Suppression of human colorectal carcinoma cell growth by wild-type p53

21 January 2018

1 reference

Two new p73 splice variants, gamma and delta, with different transcriptional activity.

21 January 2018

1 reference

Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy

21 January 2018

1 reference

Use of a membrane-localized green fluorescent protein allows simultaneous identification of transfected cells and cell cycle analysis by flow cytometry

21 January 2018

1 reference

E1A signaling to p53 involves the p19(ARF) tumor suppressor

21 January 2018

1 reference

Electroporation in ‘intracellular’ buffer increases cell survival

21 January 2018

1 reference

Direct activation of TERT transcription by c-MYC.

21 January 2018

1 reference

Viral oncoproteins discriminate between p53 and the p53 homolog p73.

21 January 2018

1 reference

Quantification of apoptosis and necrosis by flow cytometry

21 January 2018

1 reference

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Overexpression of the wild type p73 gene in human bladder cancer

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

A comparison of DNA-binding drugs as inhibitors of E2F1- and Sp1-DNA complexes and associated gene expression

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/82617

1 reference

2 September 2017

1 reference